Last reviewed · How we verify

NCT04131816

HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program

Completed NA Last updated 4 April 2022
What this trial tests

NA trial testing HeartHome in Myocardial Infarction in 14 participants. Completed in 11 February 2022.

Timeline
10 November 2019
Primary endpoint
11 February 2022
11 February 2022

Quick facts

Lead sponsorUniversity of North Carolina, Chapel Hill
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment14
Start date10 November 2019
Primary completion11 February 2022
Estimated completion11 February 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 40 to 80, any sex, with Myocardial Infarction or Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this implementation trial is to execute a nurse-led, home-based cardiac rehabilitation (HBCR) program, evaluate the program's impact on patient outcomes over 6 months; and compare outcomes of HeartHome (HH) participants to a group of participants in traditional cardiac rehabilitation (CR).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Million Hearts Cardiac Rehabilitation Think Tank: Accelerating New Care Models.
    Beatty AL, Brown TM, Corbett M, Diersing D, et al · · 2021 · cited 51× · PMID 34587751 · DOI 10.1161/circoutcomes.121.008215

Verify or expand the search:

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04131816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing